Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

BOSTON SCIENTIFIC CORPORATION (BSX)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Boston Scientific : Health Care Up On Earnings Optimism -- Health Care Roundup

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/09/2018 | 10:08pm CEST

Shares of health-care companies rose amid optimistic earnings expectations. Shares of medical-device maker Boston Scientific Corp. (>> Boston Scientific Corporation) rallied after it said it expects to report a roughly 10% increase in fourth-quarter revenue. A new Eli Lilly & Co. (>> Eli Lilly and Company) research executive said the drug maker plans to make some riskier bets on deals for experimental drugs developed by other companies, capitalizing on research-and-development cutbacks by larger competitors, The Wall Street Journal reported.

-Rob Curran, rob.curran@dowjones.com

Stocks mentioned in the article : Boston Scientific Corporation, Eli Lilly and Company
Stocks mentioned in the article
ChangeLast1st jan.
BOSTON SCIENTIFIC CORPORATION -1.24% 37.53 Delayed Quote.46.95%
ELI LILLY AND COMPANY -0.25% 113.31 Delayed Quote.30.81%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BOSTON SCIENTIFIC CORPORAT
10/16BOSTON SCIENTIFIC : Closes Acquisition of Augmenix, Inc.
PR
10/11GLOBAL CONNECTED HEALTH & WELLNESS D : Healthcare Analytics is Projected to Regi..
AQ
10/02BOSTON SCIENTIFIC CORPORATION : Report
CO
10/01BOSTON SCIENTIFIC : Competition Seeks Innovative Digital Health Concepts
PU
10/01Stryker Buys HyperBranch Medical Technology for $220 Million
DJ
10/01BOSTON SCIENTIFIC : Announces Conference Call Discussing Third Quarter 2018 Fina..
PR
10/01BOSTON SCIENTIFIC CORPORATION : Report
CO
09/24BOSTON SCIENTIFIC : Receives U.S. FDA Approval for the Eluvia™ Drug-Elutin..
PR
09/24BOSTON SCIENTIFIC CORPORATION : Report
CO
09/22BOSTON SCIENTIFIC : Eluvia Drug-Eluting Stent Demonstrates Superior Results In I..
PR
More news
News from SeekingAlpha
10/16Premarket analyst action - healthcare 
10/08Medical device makers in the red 
09/28Jefferies bullish on Boston Scientific, sees 15% upside 
09/26RA MEDICAL SYSTEMS IPO : Expensive At 30x Sales 
09/24Cardiac device makers in the green on positive data at industry conference 
Financials ($)
Sales 2018 9 851 M
EBIT 2018 2 406 M
Net income 2018 1 389 M
Debt 2018 4 936 M
Yield 2018 -
P/E ratio 2018 36,71
P/E ratio 2019 32,57
EV / Sales 2018 5,84x
EV / Sales 2019 5,34x
Capitalization 52 551 M
Chart BOSTON SCIENTIFIC CORPORATION
Duration : Period :
Boston Scientific Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC CORPORAT
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 41,6 $
Spread / Average Target 9,4%
EPS Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
John Bradley Sorenson Senior Vice President-Manufacturing & Supply Chain
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Ian T. Meredith Global Chief Medical Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORPORATION46.95%52 551
THERMO FISHER SCIENTIFIC21.87%94 516
DANAHER CORPORATION9.88%73 446
INTUITIVE SURGICAL42.29%61 755
ILLUMINA47.23%48 357
ROYAL PHILIPS10.54%38 774